NCT00912925 arm group 1b70f313c65d334a75a8ae58b6b46eb1 [clinicaltrials_resource:NCT00912925/arm-group/1b70f313c65d334a75a8ae58b6b46eb1]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00912925 arm group 1b70f313c65d334a75a8ae58b6b46eb1 [clinicaltrials_resource:NCT00912925/arm-group/1b70f313c65d334a75a8ae58b6b46eb1]
Bio2RDF identifier
NCT00912925/arm-group/1b70f313c65d334a75a8ae58b6b46eb1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 70f313c65d334a75a8ae58b6b46eb1
description [clinicaltrials_vocabulary:description]
Patients in the active treatme ...... ours once weekly for 26 weeks.
identifier
clinicaltrials_resource:NCT00912925/arm-group/1b70f313c65d334a75a8ae58b6b46eb1
title
NCT00912925 arm group 1b70f313c65d334a75a8ae58b6b46eb1
@en
type
label
NCT00912925 arm group 1b70f313 ...... 0f313c65d334a75a8ae58b6b46eb1]
@en